Partners Richard Ferris and Nathaniel Lacktman were highlighted in a Forbes article, “China’s Telemedicine Industry Gets Ready to Roar,” on March 3, 2015. The article discussed China’s health care system and the central government’s push to prioritize telemedicine. Ferris and Lacktman described the structure and use of China’s telemedicine regulations explaining that the definition includes, “Direct-to-patient telemedicine diagnostic and treatment services provided by ‘host’ institutions, remote pathological diagnosis, remote medical imaging diagnosis (including imaging, ultrasound, nuclear medicine, electrocardiograms, electromyography and electroencephalograms), remote patient monitoring, remote outpatient services and remote case discussions and other items provided by administrative authorities above the provincial levels in charge of health and family planning.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”